Previous 10 | Next 10 |
Zynex (NASDAQ: ZYXI ): Q1 GAAP EPS of $0.09 beats by $0.03 . More news on: Zynex, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
ENGLEWOOD, Colo. , April 28, 2020 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostic...
ENGLEWOOD, Colo., April 21, 2020 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological di...
One of the trends in the first quarter of 2020 has been the significant underperformance of small-cap equities as a market segment amid the extreme levels of volatility. For context, the iShares Russell 2000 ETF ( IWM ) is down about 25% compared to a 13% decline in the S&P 500 Index ( S...
Zynex ( ZYXI +10.4% ) reports 126% Y/Y order growth in Q1 and 3% sequentially growth. More news on: Zynex, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
ENGLEWOOD, Colo. , April 7, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, to...
ENGLEWOOD, Colo. , March 30, 2020 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostic...
We are currently faced with a global pandemic while at the same time faced with volatile oil prices. Many companies and industries will need a life-line to continue to stay in business. Management will face pressure from government officials with respect to capital allocation and share repurch...
Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 147 weeks of public selections as part of this ongoing live forward-testing. In...
Image source: The Motley Fool. Zynex, Inc (NASDAQ: ZYXI) Q4 2019 Earnings Call Feb 27, 2020 , 4:15 p.m. ET Operator Continue reading
News, Short Squeeze, Breakout and More Instantly...
Zynex Reports Second Quarter 2024 Financial Results PR Newswire Q2 2024 Revenue Increased 11% to $49.9 Million ENGLEWOOD, Colo. , July 25, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the ma...
Zynex Sets Second Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manage...
Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces PR Newswire ENGLEWOOD, Colo. , July 11, 2024 /PRNewswire/ -- Zy...